Oncology Cancer Care

Trusted pharma products in Oncology Cancer Care

Ibrutinib Capsules and tablets

Strength: Capsule:140 mg, 70 mg; Tablet: 140 mg

Form: Capsules and tablets

Reference Brands: Imbruvica®(US & EU)

View More Get Enquiry
Ifosfamide

Strength: 1 g/vial,2 g/vial, 3 g/vial

Form: Injection

Reference Brands: Ifex® (US), Holoxan® (EU)

View More Get Enquiry
Imatinib Mesylate

Strength: 100 / 400 mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Imatinib Mesylate

Strength: 50 mg, 100 mg, 400 mg

Form: Tablet

Reference Brands: Gleevec® (EU & US)

View More Get Enquiry
Ipilimumab

Strength: 5 mg/1 mL (vial)

Form: Injection

Reference Brands: Yervoy® (EU & US)

View More Get Enquiry
Irinotecan

Strength: 100 mg/5 mL, 300 mg/15 mL

Form: Injection/Infusion Solution

Reference Brands: Camptosar® (US & EU)

View More Get Enquiry
Ixazomib

Strength: 2.3 mg, 3 mg, 4 mg

Form: Capsules

Reference Brands: Ninlaro® (EU & US)

View More Get Enquiry
Ixazomib Capsule

Strength: 2.3mg, 3mg, 4mg

Form: Capsules

Reference Brands:

View More Get Enquiry
L-asparaginase

Strength: 5000 / 10000 IU

Form: Injection

Reference Brands:

View More Get Enquiry
L-asparaginase

Strength: 10,000 IU/vial (IV or IM injection); 2,500 IU/vial (IV infusion)

Form: IV Infusion and IV/ IM Injection

Reference Brands: Elspar® , Asparlas®, Erwinase® (US & EU)

View More Get Enquiry
Lapatinib

Strength: 250 mg

Form: Tablets

Reference Brands:

View More Get Enquiry
Lapatinib

Strength: 250 mg, 500 mg

Form: Tablet

Reference Brands: Tykerb® (EU & US)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.